Skip to main content
Top
Published in: Archives of Virology 11/2012

01-11-2012 | Original Article

New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India

Authors: Subhash Medhi, Bhabadev Goswami, Anup K. Das, Thongam Bhimo Singh, Syed Akhtar Husain, Ashok Sehgal, Premashis Kar

Published in: Archives of Virology | Issue 11/2012

Login to get access

Abstract

Northeast India is known for the demographic heterogeneity of its tribal population, but there is no information about hepatitis C virus infection and associated risk factors. Anti-HCV was measured, HCV-RNA was detected based on the 5’ UTR-core region, and genotyping was done by direct sequencing of the NS5b region. Antibodies to HCV were found in 13.7 % of the samples tested (96 out of 700), while HCV-RNA was positive in 73 % of the samples (70 out of 96) and in 5 out of 385 cases of occult HCV infection. Genotypes 1 to 4 were found respectively in 14.6, 7.3, 20, 30.8 %, and genotype 6 in 13.6 %, of the 75 HCV isolates. In acute viral hepatitis (AVH), the most prevalent genotype was 2a (28.6 %), while it was 4a (28 %) in chronic hepatitis C (CHC) and 29.4 % in cirrhosis. Males were more prone than females to HCV infection, and the highest numbers of cases of HCV infection were recorded in the age group of 40-49 years. The major risk factors were intravenous drug abuse (IVDU) (34.6 %), multiple sexual partners (20 %) and contact with professional barbers (38.6 %). The seroprevalence of HCV in Northeast India is higher than in the rest of India. This study highlights the fact that geographical variations occur with respect to HCV genotypes, which could influence the course and progress of different type of liver diseases seen in India.
Literature
1.
go back to reference Kuo G, Choo QL, Alter HJ et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364PubMedCrossRef Kuo G, Choo QL, Alter HJ et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364PubMedCrossRef
2.
go back to reference NIH Consensus Statement on Management of Hepatitis C (2002) NIH Consensus State Sci Statements 19(3):1–46 NIH Consensus Statement on Management of Hepatitis C (2002) NIH Consensus State Sci Statements 19(3):1–46
3.
go back to reference Leone N, Rizzetto M (2005) Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 51(1):31–46PubMed Leone N, Rizzetto M (2005) Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 51(1):31–46PubMed
4.
5.
go back to reference Poovorawan Y, Chatchatee P, Chongsrisawat V (2002) Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol 17(Suppl):S155–S166PubMedCrossRef Poovorawan Y, Chatchatee P, Chongsrisawat V (2002) Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol 17(Suppl):S155–S166PubMedCrossRef
6.
go back to reference Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78:321–328PubMed Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78:321–328PubMed
7.
go back to reference Okamoto H, Kojima M, Okada S et al (1992) Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190:894–899PubMedCrossRef Okamoto H, Kojima M, Okada S et al (1992) Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190:894–899PubMedCrossRef
8.
go back to reference Mizokami M, Gojobori T, Lau JYN (1994) Molecular evolutionary virology: its application to hepatitis C virus. Gastroenterology 107:1181–1182PubMed Mizokami M, Gojobori T, Lau JYN (1994) Molecular evolutionary virology: its application to hepatitis C virus. Gastroenterology 107:1181–1182PubMed
10.
go back to reference Bukh J, Purcell RH, Miller RH (1994) Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 91:8239–8243PubMedCrossRef Bukh J, Purcell RH, Miller RH (1994) Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 91:8239–8243PubMedCrossRef
11.
go back to reference Simmonds P, Holmes EC, Cha TA et al (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399PubMedCrossRef Simmonds P, Holmes EC, Cha TA et al (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399PubMedCrossRef
12.
go back to reference Maertens G, Stuyver L (1997) Genotypes and genetic variation of hepatitis. In: Harrison TJ, Zuckerman A (eds) The molecular medicine of viral hepatitis. Wiley, Chichester, pp 183–233 Maertens G, Stuyver L (1997) Genotypes and genetic variation of hepatitis. In: Harrison TJ, Zuckerman A (eds) The molecular medicine of viral hepatitis. Wiley, Chichester, pp 183–233
13.
go back to reference Chamberlain RW, Adams N, Saeed AA et al (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341–1347PubMed Chamberlain RW, Adams N, Saeed AA et al (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341–1347PubMed
14.
go back to reference Chamberlain RW, Adams NJ, Taylor LA et al (1997) The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236:44–49PubMedCrossRef Chamberlain RW, Adams NJ, Taylor LA et al (1997) The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236:44–49PubMedCrossRef
15.
go back to reference Amarapurkar D, Dhorda M, Kirpalani A et al (2001) Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 49:983–985PubMed Amarapurkar D, Dhorda M, Kirpalani A et al (2001) Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 49:983–985PubMed
16.
go back to reference Panigrahi AK, Roca J, Acharya SK et al (1996) Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 48:191–198PubMedCrossRef Panigrahi AK, Roca J, Acharya SK et al (1996) Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 48:191–198PubMedCrossRef
17.
go back to reference Raghuraman S, Shaji RV, Sridharan G et al (2003) Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 26(1):61–69PubMedCrossRef Raghuraman S, Shaji RV, Sridharan G et al (2003) Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 26(1):61–69PubMedCrossRef
18.
go back to reference Hazari S, Panda SK, Gupta SD et al (2004) Treatment of hepatitis C virus infection in patients of northern India. J Gastroenterol Hepatol 19(9):1058–1065PubMedCrossRef Hazari S, Panda SK, Gupta SD et al (2004) Treatment of hepatitis C virus infection in patients of northern India. J Gastroenterol Hepatol 19(9):1058–1065PubMedCrossRef
19.
go back to reference Chowdhury A, Santra A, Chaudhuri S et al (2003) Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 37(4):802–809PubMedCrossRef Chowdhury A, Santra A, Chaudhuri S et al (2003) Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 37(4):802–809PubMedCrossRef
20.
go back to reference Hissar SS, Goyal A, Kumar M et al (2006) Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 78(4):452–458PubMedCrossRef Hissar SS, Goyal A, Kumar M et al (2006) Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 78(4):452–458PubMedCrossRef
21.
go back to reference Valliammai T, Thyagarajan SP, Zuckerman AJ, Harrison TJ (1995) Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 76:711–716PubMedCrossRef Valliammai T, Thyagarajan SP, Zuckerman AJ, Harrison TJ (1995) Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 76:711–716PubMedCrossRef
22.
go back to reference Chandra M, Thippavuzzula R, Ramachandra Rao VV (2007) Genotyping of hepatitis C virus (HCV) in infected patients from South India. Infect Genet Evol 7(6):724–730PubMedCrossRef Chandra M, Thippavuzzula R, Ramachandra Rao VV (2007) Genotyping of hepatitis C virus (HCV) in infected patients from South India. Infect Genet Evol 7(6):724–730PubMedCrossRef
23.
go back to reference Mori S, Kato N, Yagyu A et al (1992) A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 183:334–342PubMedCrossRef Mori S, Kato N, Yagyu A et al (1992) A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 183:334–342PubMedCrossRef
24.
go back to reference Tokita H, Okamoto H, Tsuda F et al (1994) Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 91:11022–11026PubMedCrossRef Tokita H, Okamoto H, Tsuda F et al (1994) Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 91:11022–11026PubMedCrossRef
25.
go back to reference Hotta H, Handajani R, Lusida MI et al (1994) Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences. J Clin Microbiol 32:3049–3051PubMed Hotta H, Handajani R, Lusida MI et al (1994) Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences. J Clin Microbiol 32:3049–3051PubMed
26.
go back to reference Lwin AA, Shinji T, Khin M et al (2007) Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37(5):337–345PubMedCrossRef Lwin AA, Shinji T, Khin M et al (2007) Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37(5):337–345PubMedCrossRef
27.
go back to reference Simmonds P (2000) HCV Genotypes. In: Liang J, Hoofnagle JH (eds) Hepatitis C-biomedical research reports. Academic Press, USA, pp 53–70 Simmonds P (2000) HCV Genotypes. In: Liang J, Hoofnagle JH (eds) Hepatitis C-biomedical research reports. Academic Press, USA, pp 53–70
28.
go back to reference Zein NN (2000) Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223–235PubMedCrossRef Zein NN (2000) Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223–235PubMedCrossRef
29.
go back to reference Smith DB, Mellor J, Jarvis LM, The International HCV Collaborative Study Group et al (1995) Variation of the hepatitis C virus 5’ non-coding region: implications for secondary structure, virus detection and typing. J Gen Virol 6:1749–1761CrossRef Smith DB, Mellor J, Jarvis LM, The International HCV Collaborative Study Group et al (1995) Variation of the hepatitis C virus 5’ non-coding region: implications for secondary structure, virus detection and typing. J Gen Virol 6:1749–1761CrossRef
30.
go back to reference Ghany MG, Strader DB, Thomas DL, American Association for the Study of Liver Diseases (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335–1374PubMedCrossRef Ghany MG, Strader DB, Thomas DL, American Association for the Study of Liver Diseases (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335–1374PubMedCrossRef
31.
go back to reference Chinchai T, Labout J, Noppornpanth S et al (2003) Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 109:195–201PubMedCrossRef Chinchai T, Labout J, Noppornpanth S et al (2003) Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 109:195–201PubMedCrossRef
32.
go back to reference Cantaloube J-F, Gallian P, Attoui H et al (2005) Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from Southeast France. J Clin Microbiol 43:3624–3629PubMedCrossRef Cantaloube J-F, Gallian P, Attoui H et al (2005) Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from Southeast France. J Clin Microbiol 43:3624–3629PubMedCrossRef
33.
go back to reference Simmonds P, Bukh J, Combet C et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962–973PubMedCrossRef Simmonds P, Bukh J, Combet C et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962–973PubMedCrossRef
34.
go back to reference Morice Y, Roulot D, Grando V et al (2001) Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82(5):1001–1012PubMed Morice Y, Roulot D, Grando V et al (2001) Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82(5):1001–1012PubMed
35.
go back to reference Soni PN, Tait DR, Gopaul W et al (1996) Hepatitis C virus infection in chronic liver disease in Natal. S Afr Med J 86(1):80–83PubMed Soni PN, Tait DR, Gopaul W et al (1996) Hepatitis C virus infection in chronic liver disease in Natal. S Afr Med J 86(1):80–83PubMed
36.
go back to reference Ayoola EA, al-Mofleh IA, al-Faleh FZ et al (1992) Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases. Hepatogastroenterology 39(4):337–339PubMed Ayoola EA, al-Mofleh IA, al-Faleh FZ et al (1992) Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases. Hepatogastroenterology 39(4):337–339PubMed
37.
go back to reference Kim BS, Park YM (1993) Prevalence of hepatitis C virus related to liver diseases in Korea. Gastroenterol Jpn. 28(Suppl 5):17–22PubMedCrossRef Kim BS, Park YM (1993) Prevalence of hepatitis C virus related to liver diseases in Korea. Gastroenterol Jpn. 28(Suppl 5):17–22PubMedCrossRef
38.
go back to reference Sulaiman HA, Noer HM, Endardjo S, Hoyaranda E (1991) The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia. Gastroenterol Jpn 26(Suppl 3):179–183PubMed Sulaiman HA, Noer HM, Endardjo S, Hoyaranda E (1991) The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia. Gastroenterol Jpn 26(Suppl 3):179–183PubMed
39.
go back to reference Irshad M, Acharya SK (1994) Status of hepatitis viral markers in patients with acute and chronic liver diseases in northern India. Intervirology 37(6):369–372PubMed Irshad M, Acharya SK (1994) Status of hepatitis viral markers in patients with acute and chronic liver diseases in northern India. Intervirology 37(6):369–372PubMed
40.
go back to reference Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINVIR and DOSVIRC groups. Lancet 349:825–832PubMedCrossRef Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINVIR and DOSVIRC groups. Lancet 349:825–832PubMedCrossRef
41.
go back to reference Ramesh R, Munshi A, Panda SK (1992) Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol 7(4):393–395PubMedCrossRef Ramesh R, Munshi A, Panda SK (1992) Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol 7(4):393–395PubMedCrossRef
42.
43.
go back to reference Hayashi K, Fukuda Y, Nakano I, Katano Y, Yoyoda H, Yokozaki S, Hayakawa T, Morita K, Nishimura D, Kato K, Urano T, Takamatsu K (2003) Prevalence and characterization of hepatitis C virus genotyping Japanese hepatitis carriers. Hepatol Res 25:409–414PubMedCrossRef Hayashi K, Fukuda Y, Nakano I, Katano Y, Yoyoda H, Yokozaki S, Hayakawa T, Morita K, Nishimura D, Kato K, Urano T, Takamatsu K (2003) Prevalence and characterization of hepatitis C virus genotyping Japanese hepatitis carriers. Hepatol Res 25:409–414PubMedCrossRef
44.
go back to reference Das BR, Kundu B, Khandapkar R, Sahni S (2002) Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 45:323–328PubMed Das BR, Kundu B, Khandapkar R, Sahni S (2002) Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 45:323–328PubMed
45.
go back to reference Raghuraman S, Abraham P, Sridharan G et al (2004) HCV genotype 4-an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 31(4):253–258PubMedCrossRef Raghuraman S, Abraham P, Sridharan G et al (2004) HCV genotype 4-an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 31(4):253–258PubMedCrossRef
46.
go back to reference Echevarria JM, Leon P, Pozo F, Avellon A (2006) Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996–2004). Enferm Infect Microbiol Clin 24:20–25CrossRef Echevarria JM, Leon P, Pozo F, Avellon A (2006) Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996–2004). Enferm Infect Microbiol Clin 24:20–25CrossRef
47.
go back to reference Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A (2006) Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 13:19–27PubMedCrossRef Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A (2006) Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 13:19–27PubMedCrossRef
48.
go back to reference Savvas SP, Koskinas J, Sinanai C, Hadziyannis A, Spanou F, Hadziyannis SJ (2005) Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12:551–557PubMedCrossRef Savvas SP, Koskinas J, Sinanai C, Hadziyannis A, Spanou F, Hadziyannis SJ (2005) Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12:551–557PubMedCrossRef
49.
go back to reference Lwin AA, Shinji T, Khin M et al (2007) Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37:337–345PubMedCrossRef Lwin AA, Shinji T, Khin M et al (2007) Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol Res 37:337–345PubMedCrossRef
50.
go back to reference Shinji T, Kyaw YY, Gokan K, Tanaka Y, Ochi K, Kusano N, Mizushima T, Fujioka S, Shiraha H, Lwin AA, Shiratori Y, Mizokami M, Khin M, Miyahara M, Okada S, Koide N (2004) Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar. Acta Med Okayama 58(3):135–142PubMed Shinji T, Kyaw YY, Gokan K, Tanaka Y, Ochi K, Kusano N, Mizushima T, Fujioka S, Shiraha H, Lwin AA, Shiratori Y, Mizokami M, Khin M, Miyahara M, Okada S, Koide N (2004) Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar. Acta Med Okayama 58(3):135–142PubMed
51.
go back to reference Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83:1071–1078PubMedCrossRef Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83:1071–1078PubMedCrossRef
52.
go back to reference Nguyen NH, Vutien P, Garcia RT et al (2010) Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat 17:691–697PubMedCrossRef Nguyen NH, Vutien P, Garcia RT et al (2010) Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat 17:691–697PubMedCrossRef
53.
go back to reference Vutien P, Nguyen NH, Trinh HN et al (2010) Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. Am J Gastroenterol 105:1110–1115PubMedCrossRef Vutien P, Nguyen NH, Trinh HN et al (2010) Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. Am J Gastroenterol 105:1110–1115PubMedCrossRef
54.
go back to reference Mellor J, Walsh EA, Prescott LE, Jarvis LM, Davidson F, Yap PL, Simmonds P (1996) Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 34(2):417–423PubMed Mellor J, Walsh EA, Prescott LE, Jarvis LM, Davidson F, Yap PL, Simmonds P (1996) Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 34(2):417–423PubMed
55.
go back to reference Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H (1996) Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34(3):569–574PubMed Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H (1996) Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34(3):569–574PubMed
56.
go back to reference Zylberberg H, Chaix ML, Brechot C (2000) Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Letter. Ann Intern Med 132:845–846PubMed Zylberberg H, Chaix ML, Brechot C (2000) Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Letter. Ann Intern Med 132:845–846PubMed
57.
go back to reference Khan MH, Farrell GC, Byth K et al (2000) Which patients with hepatitis C develop liver complications? Hepatology 31:513–520PubMedCrossRef Khan MH, Farrell GC, Byth K et al (2000) Which patients with hepatitis C develop liver complications? Hepatology 31:513–520PubMedCrossRef
58.
go back to reference He Y, Zhang J, Zhong L, Chen X, Liu HM, Wan LK, Wang H, Li H, Tian L, Hu JL, Luo P, Wang L, Chen Y, Liu T, Liu SL, Lü WB (2011) Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu. China J Med Virol 83(4):616–621CrossRef He Y, Zhang J, Zhong L, Chen X, Liu HM, Wan LK, Wang H, Li H, Tian L, Hu JL, Luo P, Wang L, Chen Y, Liu T, Liu SL, Lü WB (2011) Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu. China J Med Virol 83(4):616–621CrossRef
59.
go back to reference van Asten L, Verhaest I, Lamzira S et al (2004) European and Italian Seroconverter Studies. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189(2):292–302PubMedCrossRef van Asten L, Verhaest I, Lamzira S et al (2004) European and Italian Seroconverter Studies. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189(2):292–302PubMedCrossRef
60.
go back to reference McHutchison JG, Manns M, Patel K, International Hepatitis Interventional Therapy Group et al (2002) Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 123(4):1061–1069PubMedCrossRef McHutchison JG, Manns M, Patel K, International Hepatitis Interventional Therapy Group et al (2002) Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 123(4):1061–1069PubMedCrossRef
61.
go back to reference De Jesús-Caraballo J, Toro DH, Rodríguez-Pérez F, Gastroenterology Association of Puerto Rico et al (2008) Sexual activity as a risk factor for hepatitis C in Puerto Rico. Bol Asoc Med P R 100(3):15–20PubMed De Jesús-Caraballo J, Toro DH, Rodríguez-Pérez F, Gastroenterology Association of Puerto Rico et al (2008) Sexual activity as a risk factor for hepatitis C in Puerto Rico. Bol Asoc Med P R 100(3):15–20PubMed
62.
go back to reference Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5’ untranslated region sequences. J Clin Microbiol 45(4):1102–1112PubMedCrossRef Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5’ untranslated region sequences. J Clin Microbiol 45(4):1102–1112PubMedCrossRef
Metadata
Title
New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India
Authors
Subhash Medhi
Bhabadev Goswami
Anup K. Das
Thongam Bhimo Singh
Syed Akhtar Husain
Ashok Sehgal
Premashis Kar
Publication date
01-11-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1374-z

Other articles of this Issue 11/2012

Archives of Virology 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.